CoP Containment


In ISPE D/A/CH, members are actively involved in regional working groups and the CoP’s (Communities of Practice). Through technical/topic-based workshops, discussions, and communication, best practice working papers and approaches are developed in the sensitive environment of patient safety. They serve as guidelines for the industry and the authorities. Members of ISPE D/A/CH participate in the ISPE Guides.


The goal of the CoP “Containment is to provide operators, planners, manufacturers as well as interested parties who deal with containment systems in their daily work with a discussion platform for technical topics and for the exchange of experiences. This objective is supported by annual expert discussions on topics in the field of “containment”. In addition, there is a regular exchange of experiences with the CoP’s of other affiliates.


The topic of containment moves the pharmaceutical industry. Many newly introduced drugs are effective even in small doses – their ingredients are highly active. For patients, this development is an opportunity; for manufacturers, it is a challenge. Low occupational exposure limits and complex toxicological assessments require special measures for process safety in the laboratory and in production.

The new Containment Manual

Now available – the new edition of the successful Containment Handbook of the Working Group.

The German Containment Handbook in the 2nd edition is available as a book.

The manual covers risk assessment, containment life cycle, process requirements, technical systems, validation, cleaning and personnel. Each chapter of the handbook begins with a definition or introduction, concepts, processes, technologies are identified and described in the form of best practices or as illustrated examples. The new EMA guidelines, “Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities”, are also taken into account.

Lead CoP Containment

Dr. Martin Schöler
Fette Compacting GmbH


Michael Maintok
Glatt GmbH


Jessica Redmer
Aicuris AG

Steering Committee

Hristina Freitag,
Vetter Pharma-Fertigungs GmbH & Co. KG

Dirk Collins,
Waldner AG

Oliver Gottlieb,
NNE (Dänemark)

Patrick Sproll,
Lonza AG

Uwe Hahmann,
HET Filter GmbH

Kolja Klein,
Pharmaplan AG

Daniela Kovats,
Fareva S.A.

Dirk Daegele,
Vetter Pharma

Dr. Andreas Schreiner,
Novartis Phama AG

Bernhard Steidle,
R-Pharm Germany GmbH

Christopher Pfanstiel,
Syntegon Technology GmbH

Dr. Rainer Nicolai
Roche AG

Birger Bockius
Merck KGaA

Dr. Reinhold Maeck,
Boehringer Ingelheim GmbH

Tim Luebke,
Bayer AG